Members

Immaculada Collet Diví (Technician)

Magda Gasull Panadès (Technician)

Natàlia Pallarès Fontanet (Technician)

José Antonio Rodríguez Pumarega (Technician)

Yolanda Rovira Pons (Research Assistant)

 

• Main Publications
• Ongoing Research Projects
• Participation in Research Networks

• Group’s Recognitions

Main Publications

• Lope V, García-Esquinas E, Pérez-Gómez B, Altzibar JM (…), Pumarega JA, Dierssen-Sotos T, Barrio-Lera JP (…), Kogevinas M, Aragonés N, Castaño-Vinyals G, Pollán M. Perinatal and childhood factors and risk of breast cancer subtypes in adulthood. Cancer Epidemiol 2016; 40: 22-30. IF 2.644. Q1.

• NCD Risk Factor Collaboration (NCD-RisC). Bentham J, Di Cesare M, Stevens GA, Zhou B, Bixby H, Cowan M, (…), Gasull M, Porta M (…),  Paciorek CJ, Riboli E, Ezzati M. A century of trends in adult human height. eLife 2016; 5: e13410. IF 8.303. Q1.

• NCD Risk Factor Collaboration (NCD-RisC). Di Cesare M, Bentham J, Stevens GA, Zhou B, Danaei G, Lu Y, (…),  Gasull M, Porta M (…),  Miranda JJ, Mostafa A, Turley ML, Paciorek CJ, Gunter M, Ezzati M. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. The Lancet 2016; 387: 1377–1396. IF 44.002. Q1.

• NCD Risk Factor Collaboration (NCD-RisC).  Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, (…), Gasull M, Porta M (…),  Pilav A, Ramachandran A, Romdhane HB, Paciorek CJ, Bennett JE, Ezzati M. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. The Lancet 2016; 387:1513–1530. IF 44.002. Q1.

• Porta M, Bolúmar F. Caution: work in progress : While the methodological "revolution" deserves in-depth study, clinical researchers and senior epidemiologists should not be disenfranchised. Eur J Epidemiol 2016; 31(6): 535-539. IF 7.105. Q1.

• Pumarega JA, Gasull M, Lee DH, López T, Porta M. Number of Persistent Organic Pollutants Detected at High Concentrations in Blood Samples of the United States Population. PLoS ONE 2016; 11(8): e0160432. IF 3.057. Q1.

• Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J (...), Porta M, Quiros JR, Riboli E (...), Stolzenberg-Solomon RS, Wolpin BM, Kraft P, Klein AP, Canzian F, Amundadottir LT. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget 2016; 7(41): 66328-66343. IF 5.008. Q1.

Ongoing Research Projects

• Plasma concentrations of organochlorine compounds and lifestyle factors pancreatic cancer risk within the EPIC cohort

− Fundació La Marató de TV3 (20132910)

− From 2014 to 2017

− Principal investigator: Porta Serra, Miquel

 

• Concentraciones sanguíneas de compuestos organoclorados, estilo de vida y riesgo de cáncer de páncreas en la cohorte EPIC

− Fondo de Investigación Sanitaria. ISCIII (PI13/00020)

− From 2014 to 2017

− Principal investigator: Porta Serra, Miquel

Participation in Research Networks

• CIBERESP: Epidemiología y salud pública

− Fondo de Investigación Sanitaria. ISCIII (CB06/02/0034)

− Principal investigator: Porta Serra, Miquel

Group’s Recognitions

• Officially recognised as a consolidated research group by the Generalitat de Catalunya: Epidemiologia Clínica i Molecular del Càncer (2014-2017)

− Agència de Gestió d’Ajuts Universitaris i de Recerca (SGR 1012)

− Principal investigator: Porta Serra, Miquel